Table 4 In hospital follow-up of the overall population and by groups.
Overall | (%) | CBOT | (%) | ProGlide | (%) | P | |
|---|---|---|---|---|---|---|---|
229 | (100%) | 135 | (59%) | 94 | (41%) | ||
Cr after TAVI (higher value during first week) | 1.4 | ± 1.2 | 1.3 | ± 0.6 | 1.6 | ± 1.6 | 0.016 |
AKI | 40/225 | (17.8) | 18 | (13.3) | 22 | (24.4) | 0.033 |
AKI stage 1 | 33/225 | (14.7) | 17 | (12.6) | 16 | (17.8) | 0.281 |
AKI stages ≥ 2 | 7/225 | (3.1) | 1 | (0.7) | 6 | (6.7) | 0.017 |
Need for RBC transfusion (1–3 days after TAVI) | 21 | (9.2) | 7 | (5.2) | 14 | (14.9) | 0.012 |
BARC type ≥ 3a bleeding | 28 | (12.2) | 14 | (10.4) | 14 | (14.9) | 0.304 |
VARC-3 type ≥ 2 bleeding | 19 | (7.4) | 5 | (3.7) | 12 | (12.8) | 0.010 |
Permanent PM implantation | 53 | (23.1) | 28 | (20.7) | 25 | (26.6) | 0.301 |
Stroke/TIA | 2 | (0.9) | 1 | (0.7) | 1 | (1.1) | 0.796 |
Death | 3 | (1.3) | 2 | (1.5) | 1 | (1.1) | 0.785 |
Mean Hospitalization (TAVI to discharge) (days) | 7.8 | ± 5.6 | 7.0 | ± 5.2 | 8.9 | ± 6.0 | 0.014 |
Pt. discharged ≤ 72 h after TAVI (n) | 32/226 | (14.2) | 27 | (20.3) | 5 | (5.4) | 0.002 |
